IRIS
CAGNACCI, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.012
AS - Asia 3.236
EU - Europa 2.377
SA - Sud America 480
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 5
Totale 18.165
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.957
SG - Singapore 1.549
UA - Ucraina 755
CN - Cina 742
BR - Brasile 412
HK - Hong Kong 404
DE - Germania 376
SE - Svezia 353
RU - Federazione Russa 237
TR - Turchia 235
IT - Italia 169
IE - Irlanda 155
VN - Vietnam 122
FI - Finlandia 87
GB - Regno Unito 84
IN - India 46
FR - Francia 25
AR - Argentina 21
CA - Canada 20
EU - Europa 20
MX - Messico 20
NL - Olanda 20
BD - Bangladesh 19
AT - Austria 18
KR - Corea 17
PL - Polonia 17
BE - Belgio 16
VE - Venezuela 16
IQ - Iraq 15
JP - Giappone 15
CZ - Repubblica Ceca 14
RS - Serbia 13
ES - Italia 11
CO - Colombia 10
EC - Ecuador 10
PK - Pakistan 10
SA - Arabia Saudita 8
EG - Egitto 6
ID - Indonesia 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
PH - Filippine 5
AU - Australia 4
CL - Cile 4
IL - Israele 4
JO - Giordania 4
KE - Kenya 4
PY - Paraguay 4
RO - Romania 4
TN - Tunisia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AM - Armenia 3
CR - Costa Rica 3
HN - Honduras 3
MD - Moldavia 3
NP - Nepal 3
AF - Afghanistan, Repubblica islamica di 2
BG - Bulgaria 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
IM - Isola di Man 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
SN - Senegal 2
TG - Togo 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 18.160
Salva come PNG Salva come JPEG
Città #
Fairfield 1.776
Woodbridge 1.286
Ashburn 1.011
Houston 892
Chandler 848
Seattle 726
Singapore 670
Wilmington 635
Cambridge 604
Ann Arbor 572
Hong Kong 401
Dearborn 395
Beijing 383
Jacksonville 357
Boardman 243
Izmir 229
Princeton 156
Dublin 155
Los Angeles 130
Des Moines 127
Dallas 114
San Diego 77
Chicago 65
Redondo Beach 65
New York 60
Buffalo 55
Dong Ket 45
Falls Church 42
Salt Lake City 41
São Paulo 36
Hefei 35
Santa Clara 33
Udine 33
Saint Petersburg 30
Norwalk 29
Kunming 28
Ogden 27
Ho Chi Minh City 26
Munich 26
Nanjing 25
Guangzhou 23
Milan 22
Hanoi 19
Grafing 17
Phoenix 17
Brussels 16
Venezia 16
Frankfurt am Main 15
Brooklyn 14
Denver 14
Brno 13
Fuzhou 13
Tampa 13
Belgrade 12
Düsseldorf 12
Nuremberg 12
Tokyo 12
Chennai 11
Jinan 11
Nanchang 11
Redmond 11
Sterling 11
Warsaw 11
Curitiba 10
Stockholm 10
Zhengzhou 10
Elk Grove Village 9
Mumbai 9
Rio de Janeiro 9
San Francisco 9
Sorocaba 9
Tappahannock 9
Toronto 9
Vienna 9
Hebei 8
Mexico City 8
Miami 8
Perth 8
Poplar 8
Rome 8
Turku 8
Amsterdam 7
Brasília 7
Chongqing 7
Gwangju 7
Porto Alegre 7
Redwood City 7
Verona 7
Atlanta 6
Baghdad 6
Belo Horizonte 6
Biên Hòa 6
Chengdu 6
Council Bluffs 6
Detroit 6
Dulles 6
Guayaquil 6
Istanbul 6
Lancaster 6
Montreal 6
Totale 13.093
Salva come PNG Salva come JPEG
Nome #
Female sexuality and vaginal health across the menopausal age 383
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 326
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 222
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 182
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 181
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 175
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 169
Regulation of the 24h body temperature rhythm of women in luteal phase: role of gonadal steroids and prostaglandins. 168
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 167
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 166
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 165
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 165
Adenomyosis of the Extrapelvic Portion of the Round Ligament 165
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 163
Association between urinary incontinence and climacteric symptoms in postmenopausal women 160
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 155
Chronic pelvic pain improvement: impact on quality of life and mood 148
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 147
A comparison of the central effects of different progestins used in hormone replacement therapy 147
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 145
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 143
Intermenstrual pelvic pain, quality of life and mood 142
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 141
Influences of maternal weight on the secondary sex ratio of human offspring 139
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 138
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 138
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 137
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 137
Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors. 136
Role of melatonin in circadian rhythm at menopause 135
Prevalence of menstrual pain in young women: what is dysmenorrhea 134
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 134
[Evolution and future of contraception.] 134
Folate administration decreases oxidative status and blood pressure in postmenopausal women 134
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 134
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 133
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 130
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 130
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. 129
Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. 128
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis 127
European society of contraception statement on contraception in obese women 127
Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women 127
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 127
Prolonged melatonin administration decreases nocturnal blood pressure in women. 126
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 126
Dienogest mediates midkine suppression in endometriosis 126
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women. 126
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 125
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 124
Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy 124
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women. 123
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 123
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 123
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 123
Course of primary headaches during hormone replacement therapy 123
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. 122
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women. 122
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 122
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 122
Management of vaginal atrophy: a real mess. Results from the AGATA study 122
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 122
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 122
Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women 121
Hormonal contraception: venous and arterial disease 121
Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy 121
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome 121
Pharmacokinetic evaluation of desogestrel as a female contraceptive 120
Hormone replacement therapy and prevention of chronic conditions 120
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 118
Thoracic ultrasound evaluation and B-type natriuretic peptide value in elective cesarean section under spinal anesthesia 118
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 118
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 117
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 116
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 116
Reply to: Interactions BetweenMelatonin and Estrogen in the Regulation of Blood Pressure 116
Intensity of menstrual pain and estimated angle of uterine flexion 116
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study 116
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement 115
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 114
Ospemifene in the management of vulvar and vaginal atrophy: Focus on the assessment of patient acceptability and ease of use 114
Season of birth influences the timing of menopause 113
Metabolic impact of combined hormonal contraceptives containing estradiol 113
Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting 113
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 113
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 113
Vaginal atrophy across the menopausal age: results from the ANGEL study 113
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 112
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 112
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 112
Kava-Kava administration reduces anxiety in perimenopausal women. 111
Interplay between maternal weight and seasons in determining the secondary sex ratio of human offspring 110
Is voluntary abortion a seasonal disorder of mood? 110
Reply to: Comment on 'Season of birth influences the timing of menopause' [7] 110
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 110
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 108
Small fetal thymus and adverse obstetrical outcome: a systematic review and a meta-analysis 108
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 108
Recommendations for contraception in women with diabetes. AMD-SIC position paper 108
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 108
Totale 13.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.550 0 0 0 0 0 370 172 237 226 92 268 185
2021/20221.368 92 101 124 93 33 96 98 54 29 210 231 207
2022/20231.930 181 104 19 256 211 587 6 140 276 24 63 63
2023/2024426 113 55 12 10 66 50 7 39 37 9 10 18
2024/20252.426 49 198 231 96 124 147 128 193 345 164 188 563
2025/20262.421 279 733 323 253 729 104 0 0 0 0 0 0
Totale 18.716